| Primary |
| Epilepsy |
40.9% |
| Convulsion |
31.8% |
| Status Epilepticus |
6.8% |
| Partial Seizures |
5.5% |
| Complex Partial Seizures |
2.4% |
| Headache |
2.1% |
| Hypertension |
1.4% |
| Vitamin Supplementation |
1.1% |
| Depression |
1.0% |
| Dyspepsia |
1.0% |
| Grand Mal Convulsion |
1.0% |
| Insomnia |
0.8% |
| Pyrexia |
0.8% |
| Diabetic Neuropathy |
0.6% |
| Asthma |
0.5% |
| Anxiety |
0.5% |
| Back Pain |
0.5% |
| Neuropathy Peripheral |
0.5% |
| Attention Deficit/hyperactivity Disorder |
0.4% |
| Gastrooesophageal Reflux Disease |
0.4% |
|
| Convulsion |
24.0% |
| Status Epilepticus |
7.1% |
| Vomiting |
5.6% |
| Dizziness |
5.2% |
| Suicidal Ideation |
4.8% |
| Weight Increased |
4.8% |
| Drug Ineffective |
4.7% |
| Death |
4.5% |
| Rash |
4.3% |
| Off Label Use |
4.2% |
| Vision Blurred |
4.2% |
| Grand Mal Convulsion |
4.0% |
| Tremor |
3.4% |
| Bradycardia |
2.9% |
| Pregnancy |
2.9% |
| Syncope |
2.9% |
| Psychotic Disorder |
2.7% |
| Diplopia |
2.6% |
| Nausea |
2.6% |
| Somnolence |
2.6% |
|
| Secondary |
| Epilepsy |
40.2% |
| Convulsion |
13.1% |
| Overdose |
9.1% |
| Partial Seizures |
6.6% |
| Product Used For Unknown Indication |
6.6% |
| Status Epilepticus |
5.0% |
| Diabetic Neuropathy |
2.9% |
| Complex Partial Seizures |
2.4% |
| Grand Mal Convulsion |
2.0% |
| Drug Use For Unknown Indication |
1.6% |
| Drop Attacks |
1.4% |
| Optic Neuropathy |
1.3% |
| Hypertension |
1.2% |
| Malaise |
1.2% |
| Odynophagia |
1.2% |
| Pyrexia |
1.2% |
| Asthma |
0.9% |
| Lennox-gastaut Syndrome |
0.8% |
| Frontal Lobe Epilepsy |
0.7% |
| Headache |
0.7% |
|
| Vomiting |
17.0% |
| Convulsion |
10.4% |
| Drug Ineffective |
7.7% |
| Status Epilepticus |
7.3% |
| Vision Blurred |
7.3% |
| Diplopia |
5.4% |
| Toxicity To Various Agents |
4.2% |
| Lymphoma |
3.9% |
| Oropharyngeal Cancer Stage Unspecified |
3.9% |
| Agranulocytosis |
3.5% |
| Death |
3.5% |
| Grand Mal Convulsion |
3.5% |
| Hypogeusia |
3.5% |
| Myocardial Infarction |
3.5% |
| Balance Disorder |
3.1% |
| Dizziness |
3.1% |
| Optic Neuropathy |
2.3% |
| Pneumonia |
2.3% |
| Urinary Tract Infection |
2.3% |
| Viral Upper Respiratory Tract Infection |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.5% |
| Epilepsy |
21.9% |
| Convulsion |
11.1% |
| Status Epilepticus |
8.8% |
| Partial Seizures |
4.3% |
| Pain |
3.1% |
| Grand Mal Convulsion |
2.5% |
| Depression |
2.1% |
| Complex Partial Seizures |
2.0% |
| Bone Marrow Conditioning Regimen |
1.8% |
| Constipation |
1.6% |
| Neutropenia |
1.6% |
| Prophylaxis |
1.6% |
| Glioblastoma |
1.4% |
| Acute Myeloid Leukaemia |
1.2% |
| Anaplastic Astrocytoma |
1.2% |
| Cataplexy |
1.2% |
| Hypertension |
1.2% |
| Osteoporosis |
1.2% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Convulsion |
7.1% |
| Psychotic Disorder |
7.1% |
| Somnolence |
7.1% |
| Suicidal Ideation |
7.1% |
| Suicide Attempt |
7.1% |
| Vomiting |
7.1% |
| Atrial Fibrillation |
5.7% |
| Weight Decreased |
5.7% |
| Blindness |
4.3% |
| Cardiac Arrest |
4.3% |
| Drug Ineffective |
4.3% |
| Hemiparesis |
4.3% |
| Hypokalaemia |
4.3% |
| Stomatitis |
4.3% |
| Tremor |
4.3% |
| Weight Increased |
4.3% |
| Death |
2.9% |
| Diarrhoea |
2.9% |
| Dysarthria |
2.9% |
| Dystonia |
2.9% |
|
| Interacting |
| Epilepsy |
38.6% |
| Convulsion |
19.3% |
| Partial Seizures |
13.3% |
| Complex Partial Seizures |
6.9% |
| Drop Attacks |
5.8% |
| Grand Mal Convulsion |
5.8% |
| Product Used For Unknown Indication |
5.8% |
| Menopause |
1.2% |
| Depression |
0.6% |
| Cardiac Disorder |
0.3% |
| Hypertonic Bladder |
0.3% |
| Irritable Bowel Syndrome |
0.3% |
| Off Label Use |
0.3% |
| Schizophrenia |
0.3% |
| Status Epilepticus |
0.3% |
| Supplementation Therapy |
0.3% |
| Vitamin D Deficiency |
0.3% |
| Weight Control |
0.3% |
| Weight Decreased |
0.3% |
|
| Diplopia |
19.5% |
| Drug Interaction |
17.2% |
| Neurotoxicity |
12.6% |
| Dizziness |
6.9% |
| Toxicity To Various Agents |
6.9% |
| Anticonvulsant Drug Level Decreased |
5.7% |
| Balance Disorder |
4.6% |
| Malnutrition |
3.4% |
| Ataxia |
2.3% |
| Convulsion |
2.3% |
| Depressed Level Of Consciousness |
2.3% |
| Drug Toxicity |
2.3% |
| Hyperammonaemic Encephalopathy |
2.3% |
| Neuroleptic Malignant Syndrome |
2.3% |
| Vertigo |
2.3% |
| Vision Blurred |
2.3% |
| Dysarthria |
1.1% |
| Feeling Abnormal |
1.1% |
| Nausea |
1.1% |
| Off Label Use |
1.1% |
|
